Gofen & Glossberg LLC Northwest Biotherapeutics Inc Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
A detailed history of Gofen & Glossberg LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Gofen & Glossberg LLC holds 12,740 shares of NWBO stock, worth $3,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,740
Previous 12,740
-0.0%
Holding current value
$3,312
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
746KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC489KShares$127,0150.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$17,0490.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,1000.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,1620.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...